Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Venomous Animals and Toxins Including Tropical Diseases|May 28, 2019
Functional and biological insights of rCollinein-1, a recombinant serine protease from <i>Crotalus durissus collilineatus</i>Johara Boldrini-França, Ernesto Lopes Pinheiro-Junior, Eliane Candiani Arantes
Marine Drugs|February 24, 2022
A Tale of Toxin Promiscuity: The Versatile Pharmacological Effects of Hcr 1b-2 Sea Anemone Peptide on Voltage-Gated Ion ChannelsErnesto Lopes Pinheiro-Junior, Rimma Kalina, Irina Gladkikh, et al.
International Journal of Molecular Sciences|July 27, 2022
Pharmacological Screening of Venoms from Five Brazilian <i>Micrurus</i> Species on Different Ion ChannelsJessica Matos Kleiz-Ferreira, Hans Bernaerts, Ernesto Lopes Pinheiro-Junior, et al.
Marine Drugs|February 24, 2022
AsKC11, a Kunitz Peptide from <i>Anemonia sulcata</i>, Is a Novel Activator of G Protein-Coupled Inward-Rectifier Potassium ChannelsDongchen An, Ernesto Lopes Pinheiro-Junior, László Béress, et al.
Marine Drugs|April 26, 2024
Attenuation of Nicotine Effects on A549 Lung Cancer Cells by Synthetic α7 nAChR Antagonists APS7-2 and APS8-2Ahmad Joukhan, Veno Kononenko, Tadeja Bele, et al.
Bioorganic Chemistry|August 20, 2021
Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinitiesAya M Emam, Steve Peigneur, Anne-Sophie Depuydt, et al.
Biomedicines|November 7, 2020
Kunitz-Type Peptides from the Sea Anemone <i>Heteractis crispa</i> Demonstrate Potassium Channel Blocking and Anti-Inflammatory ActivitiesIrina Gladkikh, Steve Peigneur, Oksana Sintsova, et al.
Pharmaceutics|September 23, 2022
New Diarylamine K<sub>V</sub>10.1 Inhibitors and Their Anticancer PotentialŠpela Gubič, Žan Toplak, Xiaoyi Shi, et al.
Frontiers in Pharmacology|October 3, 2022
Apamin structure and pharmacology revisitedAlexey I Kuzmenkov, Steve Peigneur, Joshua A Nasburg, et al.
BMC Biology|July 29, 2024
Diversely evolved xibalbin variants from remipede venom inhibit potassium channels and activate PKA-II and Erk1/2 signalingErnesto Lopes Pinheiro-Junior, Ehsan Alirahimi, Steve Peigneur, et al.
Pageof 2